Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY
Baxter International (NYSE: BAX) announced its fourth-quarter 2024 financial results, reporting revenues of USD 2.75...
Baxter
Vantive Launches as Standalone Vital Organ Therapy Company Post Carlyle Acquisition
Vantive, formerly the Baxter Kidney Care segment, has announced its launch as a new standalone...
Baxter Appoints Wu Xin as China General Manager Amid Spin-Off of Kidney Care Business
Baxter (NYSE: BAX), a leading provider of healthcare products, has announced the appointment of Wu...